Here, we demonstrate that CC-115 is a selective mTOR kinase/DNA-PK dual inhibitor with excellent kinase selectivity, even over closely related ATR, ATM and PI3K-alpha and with potent inhibitory activity across many cancer cell lines. This evidence concerns the gene PRKDC and cancer.